Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROADMAP: Olmesartan for Microalbuminuria Prevention
NCT00185159Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2004
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan in diabetic nephropathy (DN), sponsored by Daiichi Sankyo Co., Ltd.. Started Oct 2004; status: completed.
02
Drugs
olmesartan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00185159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185159.